P2-14-62 (B). 1L Pembrolizumab With/Without Lenvatinib in Metastatic NSCLC : Phase 3, Randomized, LEAP-007 Trial

Journal article

Kaoru Kubota, Tarek Mekhail, Sang-We Kim, Mariana Riego, Larry Wu, Ayman Samkari, Tamer Fouad, James Yang and Eisai Inc

Japanese Journal of Lung Cancer, Vol.60(6), pp.710-710

20 Oct 2020

Additional Links

5 Record Views

Title: P2-14-62 (B). 1L Pembrolizumab With/Without Lenvatinib in Metastatic NSCLC : Phase 3, Randomized, LEAP-007 Trial
Creators: Kaoru Kubota
Tarek Mekhail
Sang-We Kim
Mariana Riego
Larry Wu
Ayman Samkari
Tamer Fouad
James Yang
Eisai Inc
Publication Details: Japanese Journal of Lung Cancer, Vol.60(6), pp.710-710
Publisher: The Japanese Lung Cancer Society
Resource Type: Journal article
Language: Japanese
Academic Unit: Pediatrics
Identifiers: 991021838681404721